期刊文献+

瑞波西汀抗抑郁作用的非转运体抑制机制研究 被引量:6

Anti-depressive effect of reboxetine on non-transporter inhibition in rats
原文传递
导出
摘要 目的探讨瑞波西汀抗大鼠抑郁作用与改善氧化应激平衡、HPA轴功能及脑源性神经营养因子(brainderived neurotrophic factor,BDNF)表达的关系。方法 60只雄性SD大鼠,随机分为对照组(NG)、模型组(MG)、灌胃给予瑞波西汀[0.7 mg/(kg.d)]正常组(RNG)和灌胃给予瑞波西汀[0.7 mg/(kg.d)]模型组(RMG)。采用孤养结合慢性轻度不可预见刺激(chronic unpredictable mild stress,CUMS)方法建立大鼠抑郁模型。以高架迷宫法、生物化学方法、放射免疫法、免疫组化染色法和RT-PCR评价大鼠抑郁行为,检测皮质丙二醛(malondialdehyde,MDA)含量、超氧化物歧化酶(superoxide dismutase,SOD)和过氧化氢酶(catalase,CAT)的活性,血清皮质酮(corticosterone,CORT)和海马BDNF水平,以及下丘脑促肾上腺皮质激素释放因子(corticotropin releasing factor,CRF)mRNA表达。结果与NG组相比,MG组大鼠进入开臂次数和向下探究的次数明显减少(P<0.01),在开臂停留时间明显减少(P<0.05),而在闭臂停留的时间明显升高(P<0.05),皮质MDA含量明显升高(P<0.05),SOD和CAT活性显著下降(P<0.05),血清CORT浓度增加(P<0.05),海马BDNF mRNA表达和蛋白表达明显降低(P<0.01),下丘脑CRF mRNA表达显著增加(P<0.01)。瑞波西汀给予明显阻遏CUMS诱导的上述变化,但对正常组大鼠无显著影响。结论瑞波西汀的抗抑郁作用可能涉及其逆转机体氧化/抗氧化应激系统失衡,改善HPA轴功能,增加海马BDNF表达。 study the relation of reboxetine' s anti-depression effect with oxidative stress balance, HPA axis function and brain derived neurotrophic factor (BDNF) expression. Methods Sixty male SD rats were randomly divided into normal control group (NG), model group (MG), reboxetine-treated normal group ( RNG), and reboxetine-treated model group (RMG). Reboxetine of 0.7μg/( μg / d) was administered to RNG and RMG rats through intragastric gavage. A rat depressive model was induced by chronic unpredictable mild stress(CUMS). Depressive behaviors of rats, level of MDA and activities of SOD and cata/ase (CAT) in cortex, serum corticosterone (CORT) and hippocampus BDNF level, mRNA expressions of hippocampus BDNF and hypothalamus corticotropin releasing factor (CRF), were measured by elevated plus maze (EPM), biochemistry, radioimmunity, immunohistochemical staining, and RT-PCR, respectively. Results The frequency for MG rats to enter the open arms and to explore downward significantly decreased, whereas the time for MG rats to stay in open arms was significantly shorten but the time to stay in close arms was significantly prolonged,compared with NG rats (P 〈0.01, P 〈0.05). The levels of MDA and CORT and CRF mRNA expression significantly increased, but the activities of SOD and CAT and BDNF mRNA and protein expressions significantly decreased in MG rats, compared with NG(P 〈 0.05, P 〈 0. O1 ). Reboxetine treatment effectively prevented CUMS-induced the changes above in RMG rats, but failed to influence on RNG rats. Conclusion The anti-depression effect of reboxetine can improve the depressive behaviors of rats and up-regulate the BDNF expression in hippocampus by reversing the oxidative stress and anti-oxidative stress imbalance and improving the HPA axis function.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2012年第19期1977-1980,共4页 Journal of Third Military Medical University
关键词 瑞波西汀 慢性轻度不可预见刺激 抗抑郁 氧化应激 HPA轴 脑源性神经营养因子 reboxetine chronic unpredictable mild stress depression oxidative stress HPA axis brain-derived neurotrophic factor
  • 相关文献

参考文献14

  • 1Trew J L. Exploring the roles of approach and avoidance in depression : an integrative model[J]. Clin Psychol Rev, 2011, 31 (7) : 1156 -1168.
  • 2Herken H,Gurel A, Selek S, et al. Adenosine deaminase,nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment[ J]. Arch Med Res, 2007, 38(2): 247 -252.
  • 3Kolber B J, Boyle M P, Wieczorek L, et al. Transient early-life forebrain corticotropin-releasing hormone elevation causes long-lasting anxiogenic and despair-like changes in mice[ J ]. J Neurosci,2010,30 (7) : 2571 -2581.
  • 4曾妍,杨健,况利.伴抑郁症状的慢性丙型肝炎患者的血清BDNF表达与生存质量的相关性分析[J].第三军医大学学报,2011,33(21):2274-2277. 被引量:3
  • 5Benson N, Snelder N, Ploeger B,et al. Estimation of binding rate constants using a simultaneous mixed-effects method : application to monoamine transporter reuptake inhibitor reboxetine[ J]. Br J Pharmacol, 2010, 160(2) : 389 -398.
  • 6魏伟,吴希美,李元建.药理实验方法学[M].第4版.北京;人 民卫生出版社,2008: 63 -66.
  • 7Willner P, Towell A,Sampson D, et al. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricy-clic antidepressant[ J]. Psychopharmacology ( Berl) , 1987,93(3): 358 -364.
  • 8Willner P. Validity, reliability and utility of the chronic mild stress model of depression : a 10-year review and evaluation [ J ]. Psycho-phamiacology ( Berl),1997,134(4) : 319 -329.
  • 9Bilici M, Efe H,Koroglu A, et al, Antioxidative enzyme activities and lipid peroxidation in major depression : alterations by antidepressant treatmenta[ J]. J Affect Disord, 2001,64( i ) ; 43 -51.
  • 10Cattaneo A, Bocchio-Chiavetlo L, Zanardini R, et al. Reduced peripheral brain-derived neurotrophic factor mHNA levels are normalized by antidepressant treatment[ J]. Int J Neuropsychophamiacol, 2010, 13(1): 103 -108.

二级参考文献17

  • 1周宝桐,范蕴明,李德明,刘晓清.两种聚乙二醇干扰素联合利巴韦林治疗1b及6a亚型慢性丙型肝炎的疗效[J].中国医学科学院学报,2010,32(3):320-323. 被引量:14
  • 2Lee H Y, Kim Y K. Plasma brain-derived neurotrophic factor as a pe- ripheral marker for the action mechanism of antidepressants[ J]. Neu- ropsychobiology, 2008, 57 (4) : 194 - 199.
  • 3Chang S C, Ko W S, Wu S S, et al. Factors associated with quality of life in chronic hepatitis C patients who received interferon plus riba- virin therapy[J]. J Formos Med Assoe, 2008, 107(6) : 454 -462.
  • 4Sinakos E, Gigi E, Lalla T, et al. Health-related quality of life in Greek chronic hepatitis C patients during pegylated interferon and ribavirin treatment [ J ]. Hippokratia, 2010, 14 (2) : 122 - 125.
  • 5Sockalingam S, Abbey S E. Managing depression during hepatitis C treatment[J]. Can J Psychiatry-, 2009, 54(9) : 614 -625.
  • 6Raison C L, Broadwell S D, Borisov A S, et al. Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C [ J]. Brain Behav Immun, 2005, 19( 1 ) : 23 -27.
  • 7Rifai M A, Gleason 0 C, Sabouni D. Psychiatric care of the patient with hepatitis C : a review of the literature [ J ]. Prim Care Companion J Clin Psychiatry, 2010, 12(6) : 1523.
  • 8Lim J K, Cronkite R, Goldstein M K, et al. The impact of chronic hepatitis C and comorbid psychiatric illnesses On health-related quality of life~J]. J Clin Gastroenterol, 2006, 40(6) : 528 -534.
  • 9Phillips F H, Prebis M, Grumbeck C, et al. Effects of recognizing de- pression with a standardized questionnaire (CES-D) versus patient re- porting of depression after a single-standardized question on the out- comes of treatment for hepatitis C with pegylated interferon-α2b and ribavirin[J]. Eur J Gastroenterol Hepatol, 2010, 22 (12): 1435 - 1442.
  • 10Lee B H, Kim Y K. The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment [ J ]. Psychiatry Investig, 2010, 7(4) : 231 -235.

共引文献10

同被引文献69

  • 1Lin Y, Sarfraz Y, Jensen A,et al. Participation of brainstem monoaminergic nuclei in behavioral depression. Pharmacol Biochem Be, 2011, 100 : 330 -339.
  • 2Herken H, Gurel A, Selek S, et al. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res, 2007, 38 : 247 - 252.
  • 3Romano-Torres M, Fernandez-Guasti A. Estradiol valerate e?licits antidepressant -like effects in middle-aged female rats under chronic mild stress. Behav Pharmacol, 2010, 21 : 104 -111.
  • 4Karakaya S, Kipp M, Beyer C. Oestrogen regulates the ex?pression and function of dopamine transporters in astrocytes of the nigrostriatal system. J Neuroendocrinol, 2007, 19 : 682 -690.
  • 5Rajkowska G, Miguel-Hidalgo JJ. Gliogenesis and glial pa?thology in depression. CNS Neurol Disord Drug Targets, 2007,6: 219 -233.
  • 6Crespi F. Influence of neuropeptide Y and antidepressants upon cerebral monoamines involved in depression: An in vi?vo electrochemical study. Brain Res, 2011, 1407 : 27- 37.
  • 7Morales-Medina JC, Dumont Y, Benoit CE, et al. Role of neuropeptide Y Y -1 and Y -2 receptors on behavioral despair in a rat model of depression with co-morbid anxiety. Neurop?harmacology, 2012, 62: 200 - 208.
  • 8Mickey BJ, Zhou ZF, Heitzeg MM, et al. Emotion process?ing, major depression, and functional genetic variation of neuropeptide Y. Arch Gen Psychiat , 2011, 68: 158 -166.
  • 9Dworkin S, Heath JK, delong-Curtain TA,et al. CREB ac?tivity modulates neural cell proliferation, midbrain-hind?brain organization and patterning in zebrafish. Dev Bioi, 2007, 307: 127 - 141.
  • 10Harrison NA, Brydon L, Walker C, et al. Neural origins of human sickness in interoceptive responses to inflammation. Bioi Psychiatry, 2009, 66: 415 - 422.

引证文献6

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部